a fiba nd glutathione & Diabetes: How the Body's Master Antioxidant Built for long Glutathione Cell Defense

M., Gray, K

Comparison with Similar Peptides GHK-Cu (Current) Half-Life:~2 hours Dosage:1-2 mg daily Administration:Topical or subcutaneous Research Status: Preclinical/Experimental Half-Life:~4 hours Dosage:200-500 mcg daily Administration:Subcutaneous injection Research Status: Preclinical/Experimental Half-Life:~2-3 days Dosage:2-5 mg per week Administration:Subcutaneous injection Research Status: Preclinical/Experimental Half-Life:~2-3 hours Dosage:2-4 IU daily Administration:Subcutaneous injection Research Status: FDA Approved (for specific conditions) Half-Life:~24 hours Dosage:10-25 mg daily Administration:Oral Research Status: Experimental Half-Life:~12 minutes Dosage:1-2 mg daily Administration:Subcutaneous injection Research Status: FDA Approved (for specific conditions) Highlighted rowcard shows the current peptide

Plus, the airless pump (which is made with 50% post-consumer recycled plastic) helps keep the juice fresh by the time it reaches your skin

Low-dose methylene blue supports mitochondrial energy, cognitive clarity, and antioxidant defense a small-molecule complement to peptide-based longevity protocols